Think Outside the Eye

Skin and eyelid inflammation affects millions of Americans every year. Over 85% of skin and eyelid inflammation patients also suffer from inflammatory ocular conditions, such as Meibomian Gland Dysfunction (MGD), blepharitis, eyelid inflammation and eyelid telangiectasia1.

Lumenis invites you to think outside the eye and offer your patients a solution to their skin inflammation and skin related problems with M22™. M22™ combines Intense Pulsed Light (IPL) with unique Optimal Pulse Technology (OPT™), and is FDA cleared for 20 different skin indications, including rosacea treatment and other skin inflammatory conditions2.

IPL: An Excellent Technology for Treating Skin and Eyelid Inflammation

Inflammatory skin diseases are characterized by the formation of vascular abnormalities, which release inflammatory agents. When occurring in proximity to the eyes, these mediators propagate via the orbital vasculature to the eyelids, often resulting in inflammation of the eyelids and triggering ocular complications.

IPL is an excellent technology for treating vascular skin lesions. IPL is selectively absorbed in the hemoglobin of abnormal blood vessels, and destroys them by thrombosis. A major source of inflammation threatening the eyelids is then removed.

Download the brochure here

M22 IPL with OPT Treatment from Lumenis on Vimeo.

Source

Comments

comments